" class="no-js "lang="en-US"> Grip - Medtech Alert
Sunday, September 21, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Grip | Pharmtech Focus

Grip

About Grip

Grip

Grip gives anyone with ovaries insight into their hormonal health and (future) fertility, through a simple at home blood test. “Just start trying, and see if you get pregnant” is no longer good enough. Whether you’re years away from having a kid or have already started trying, understanding your fertility will help you plan better.

Related Story

Industry News

 Hertility Acquires Competitor Grip as the Two Female-founded Companies Join Forces in a United Goal to Revolutionise Women’s Health | Pharmtech Focus

Hertility Acquires Competitor Grip as the Two Female-founded Companies Join Forces in a United Goal to Revolutionise Women’s Health

May 16 2022

Today, women’s health company Hertility is announcing the acquisition of Netherlands-based fertility and hormone testing […]